0001905945-22-000002.txt : 20220907 0001905945-22-000002.hdr.sgml : 20220907 20220907115317 ACCESSION NUMBER: 0001905945-22-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220907 DATE AS OF CHANGE: 20220907 EFFECTIVENESS DATE: 20220907 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Rejuvitas, Inc. CENTRAL INDEX KEY: 0001905945 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-458186 FILM NUMBER: 221230420 BUSINESS ADDRESS: STREET 1: 335 OLD MILL FARM CITY: NISSEQUOGUE STATE: NY ZIP: 11780 BUSINESS PHONE: 516-448-6051 MAIL ADDRESS: STREET 1: 335 OLD MILL FARM CITY: NISSEQUOGUE STATE: NY ZIP: 11780 D 1 primary_doc.xml X0708 D LIVE 0001905945 Rejuvitas, Inc. The Lasker Biomedical Research Building 3960 Broadway, 6th Floor New York NY NEW YORK 10032 516-448-6051 DELAWARE None None Corporation true 2021 Andrea Spezzi The Lasker Biomedical Research Building 3960 Broadway, 6th Floor New York NY NEW YORK 10032 Executive Officer Director Eric Heil The Lasker Biomedical Research Building 3960 Broadway, 6th Floor New York NY NEW YORK 10032 Director John Prufeta The Lasker Biomedical Research Building 3960 Broadway, 6th Floor New York NY NEW YORK 10032 Director Biotechnology Decline to Disclose 06b false 2022-08-31 false true false 0 4999996 4999996 0 false 3 0 0 0 false Rejuvitas, Inc. /s/ Andrea Spezzi Andrea Spezzi Chief Executive Officer 2022-09-07